Claim Deadline: October 15, 2025
Estimated Payout: $10+
Proof of Purchase Required: No (higher payout with proof)
Similasan Corporation has agreed to a $3.575 million class action settlement to resolve claims that it falsely advertised and labeled its homeopathic eye drops. The lawsuit alleged the products were misrepresented as FDA-approved, sterile, and compliant with manufacturing standards, and failed to disclose the risk of silver sulfate. Similasan denies these claims but has agreed to settle.
You may be eligible for compensation if you purchased any Similasan, CVS, or Walgreens branded eye drops listed below in the U.S. between September 11, 2017, and February 20, 2025, for personal use.
Submit your claim online or by mail no later than October 15, 2025. Claims submitted after this date will not be eligible for payment.
Claim Submission Site: [Settlement Website]
Please be aware that your claim form will be rejected if it contains fraudulent information. By submitting your information and your sworn statement of its accuracy, you are agreeing to do so under penalty of perjury. Submitting false information not only jeopardizes your claim but also affects others who are genuinely eligible for the settlement. If you are uncertain about your eligibility for this class action settlement, please visit the class action administrator’s website for more information. Note that NoProofClassActions.org participates in the Amazon affiliate advertising program, and this post may include affiliate links, which could result in us earning a commission if you make a purchase through those links.